Form4.ai tracks every SEC insider trade in real time. See every KNSA insider filing with a free account — no card.
See every KNSA insider filing — free account, no card.
Free accountKiniksa Pharmaceuticals International, plc (KNSA) has 12 SEC Form 4 insider filings on record in the last 90 days. No insider purchases were filed — 3 sales totalling $54.7M. Most recent filing: Nov. 3, 2026.
Open-market value, last 90 days
Form 4 filings by type, last 90 days
| Date | Insider | Trade | Value | Price since buy |
|---|---|---|---|---|
| Nov 3, 2026 SEC filing | Patel Sanj K CHAIRMAN & CEO | Sold | $15,913,449 | — |
| Nov 3, 2026 SEC filing | Ragosa Mark CHIEF FINANCIAL OFFICER | Cashless exercise | $2,994,190 | — |
| Nov 3, 2026 SEC filing | Paolini John F. CHIEF MEDICAL OFFICER | Vest & sell-to-cover | 0 sh | — |
Create a free account to see all 12 KNSA filings from the last 90 days. No card needed.
Create free accountWant KNSA insider buys the moment they're filed, with Telegram alerts? Try Pro free for 7 days
Form 4 is the filing company officers, directors and 10% shareholders must submit to the SEC within two business days of trading their own company's stock. Open-market purchases generally carry more signal than sales, which are often scheduled in advance. More on how this works.